DISC1 (Disrupted-in-Schizophrenia 1) Model Development Service

Are you currently facing long drug development cycles, limited translational relevance of current models, or difficulty in identifying precise mechanistic insights for complex psychiatric disorders? Creative Biolabs' DISC1 model development services help you accelerate drug discovery, obtain highly predictive and translatable models, and elucidate complex disease mechanisms through advanced gene editing (CRISPR/Cas9), patient-derived iPSC technology, and sophisticated in vivo phenotyping platforms.

DISC1 is a pivotal genetic risk factor consistently implicated in a spectrum of severe psychiatric and neurological disorders. This multifunctional scaffolding protein plays critical roles in neurodevelopment, synaptic plasticity, and intracellular signaling, making it a crucial target for understanding disease pathology and developing novel therapeutics. CBL leverages extensive expertise and cutting-edge technologies to provide comprehensive DISC1 model development services, empowering researchers to overcome current challenges in psychiatric drug discovery.

Workflow Advantages Available Models Offerings Related Services

How Our DISC1 Model Development Services Can Assist Your Project?

Our DISC1 model development services provide bespoke solutions for your most critical neuroscience research needs. Clients can expect custom-generated iPSC lines or genetically engineered animal models precisely recapitulating DISC1-related pathologies. We deliver comprehensive phenotypic characterization encompassing electrophysiological, behavioral, and neurochemical analyses, alongside robust target validation studies. Our expertise helps you pinpoint precise disease mechanisms and evaluate therapeutic candidates with high fidelity.

Discover How We Can Help - Request a Consultation

Workflow: Precision Modeling from Concept to Discovery

Our workflow is designed for clarity, efficiency, and scientific rigor, guiding your project through every stage from initial design to final deliverables, and is suitable for visualization as a flowchart.

Required Starting Materials:
1. Specific Research Objectives: A clear outline of your project's goals, whether for target identification, compound screening, mechanistic studies, or preclinical validation.
2. Patient Genetic Information: If leveraging patient-derived iPSC models, details of patient-specific DISC1 mutations or relevant genetic backgrounds are essential. For engineered models, precise genetic modifications or desired gene disruption strategies are required.
3. Relevant Existing Data or Preliminary Hypotheses: Any foundational research, preliminary findings, or specific hypotheses you wish to test will inform our model design and experimental strategy.

Fig.1 Workflow of our DISC1 (Disrupted-in-Schizophrenia 1) Model Development Services. (Creative Biolabs Original)

Final Deliverables:
1. Comprehensive Scientific Report: A meticulously detailed document covering methodologies, all experimental results, statistical analyses, and expert interpretations.
2. Raw and Analyzed Data Sets: Full access to all raw data files (e.g., electrophysiological traces, behavioral scores, imaging files) and corresponding analyzed data in easily accessible formats.
3. Validated DISC1 Cell Lines or Animal Cohorts: (Optional) Transfer of the generated and validated DISC1 iPSC lines or breeding animal cohorts, complete with full characterization data, for your in-house research.
Estimated Timeframe: The typical timeframe for our DISC1 model development services ranges from 12 to 24 weeks for iPSC-based models and 20 to 40 weeks for animal models. The exact duration depends on the complexity of the genetic modification, the scope of phenotypic characterization requested, and the cohort size.

Why Choose Us?

Choosing CBL for your DISC1 model development services means partnering with a leader in neuroscience research. Our deep scientific knowledge, cultivated over two decades, combined with access to state-of-the-art technologies, ensures that your projects are handled with unparalleled expertise and precision. We are committed to generating models with high translational relevance, meticulously characterized to provide accurate and predictive insights for psychiatric drug discovery. Our ability to create custom models, including those investigating sex-specific effects and complex gene-environment interactions, sets us apart. Rigorous quality control is embedded in every stage of our process, guaranteeing reliable and reproducible results.

Experience the Advantage - Get a Quote Today

Customer Reviews: Trusted by Leading Researchers

Improved Mechanistic Understanding: "Using iPSC models in our research has significantly improved our ability to dissect the molecular mechanisms underlying patient-specific phenotypes. " 10 months ago, Dr. Ar S*h.

DISC1 (Disrupted-in-Schizophrenia 1) Model

DISC1's pervasive influence on brain health stems from its diverse biological functions and its central role as a master regulator. Genetically, variants and disruptions within the DISC1 locus are consistently linked to increased susceptibility for schizophrenia, bipolar disorder, major depressive disorder, schizoaffective disorder, and autism spectrum disorders. Its complexity is further highlighted by the existence of numerous DISC1 isoforms with distinct expression profiles throughout development.

Our Modeling Approaches:

CBL employs both in vitro and in vivo approaches to comprehensively model DISC1 dysfunction:

Models	Description
In Vitro Modeling with iPSCs	We develop patient-derived human induced pluripotent stem cell (iPSC) lines that carry specific DISC1 mutations, which are then differentiated into relevant neural cell types such (e.g., cortical neurons, interneurons, glia). These models provide unparalleled human relevance and scalability for phenotypic drug discovery. Our characterization includes detailed electrophysiological readouts, such as altered neuronal excitability, impaired sodium channel function, and changes in action potential inter-spike intervals (AP-ISI), mirroring those found in patient-derived neurons.
In Vivo Animal Models	Our custom rodent models (primarily mice and rats) are precisely engineered to mimic human DISC1 alterations or functional disruptions. This includes transgenic models expressing dominant-negative DISC1 variants that exhibit schizophrenia-related phenotypes like enlarged ventricles, reduced parvalbumin expression, hyperactivity, and deficits in sensorimotor gating. We also utilize DISC1 knockdown models, which can show aberrant neurogenesis and altered dendritic growth. These models are crucial for investigating complex behaviors, brain circuitry, and gene-environment interactions, including the impact of juvenile immune activation (JIA) and sex-specific behavioral and neurochemical responses.
CRISPR/Cas9 Technology	Central to both our in vitro and in vivo platforms, CRISPR/Cas9 gene editing allows us to create precise and controlled DISC1 mutations, engineer isogenic cell lines, or generate animal models with specific gene deletions or modifications. This technology ensures high fidelity and allows for the study of complex gene-gene interactions (e.g., DISC1 with Reelin) to better understand multifactorial disease etiologies.

By combining these advanced modeling strategies, CBL offers powerful platforms for dissecting DISC1 pathology, validating therapeutic targets, and advancing drug discovery for psychiatric disorders.

What We Can Offer: Tailored Solutions for Your DISC1 Research

As a leading provider in neuroscience model development, CBL is committed to delivering custom-tailored solutions for your specific DISC1 research challenges. We empower biology experts like you to achieve groundbreaking discoveries with unmatched precision and support.

Customized Model Generation: From patient-derived iPSCs to precisely engineered rodent models, we offer a one-stop service for developing DISC1 models that perfectly match your research specifications, ensuring genetic and phenotypic accuracy.
Efficient Upstream & Downstream Process Development: Our expert team streamlines the entire model development pipeline, from initial genetic engineering and cell line derivation to comprehensive phenotyping and data analysis, maximizing efficiency for your projects.
Scalable Modeling Platforms: We provide robust capabilities for generating and characterizing DISC1 models at various scales, whether you require diverse iPSC lines for high-throughput screening or large cohorts of in vivo models for preclinical validation studies.
Strict Aseptic Verification & Cell Bank Stability: We implement stringent aseptic verification procedures for all cell culture processes, guaranteeing the stability and integrity of cell banks and ensuring consistent, reproducible results for your in vitro DISC1 models.
Rigorous Model Characterization: We guarantee the stability and phenotypic consistency of our DISC1 models in both cell banks and across in vivo cohorts, providing you with reliable and reproducible research tools.
Optimized Genetic and Experimental Conditions: Our specialists can optimize gene expression strategies (e.g., codon usage for specific microorganisms if applicable) and culture conditions to maximize the disease-relevant phenotypes and ensure the highest utility of your DISC1 models.
High Standard Quality Control Tools: We utilize advanced quality control tools to rigorously quantify and evaluate the genetic integrity and phenotypic relevance of all our DISC1 models, providing you with absolute confidence in your research tools.

Related Services

To further support your comprehensive neuroscience research and drug discovery initiatives, CBL offers a suite of complementary services and specialized variations of our DISC1 model development services. These offerings are designed to address various aspects of neurological and psychiatric research, providing end-to-end solutions.

Target Identification & Validation
Compound Screening & Profiling
Pharmacokinetic/Pharmacodynamic (PK/PD) Studies
Neuroinflammation Research Models

Ready to advance your neuroscience research? Partner with us to leverage our unparalleled expertise in DISC1 Model Development Services.

Contact Our Team for More Information and to Discuss Your Project.

For Research Use Only. Not For Clinical Use.

In Vivo Services

Hot Products

Antibodies

Cells

Kits

Tracers

Gene Therapy Tools

Biospecimens

Cell Assay Reagents